Cited 3 time in
4 '-O-beta-D-Glucosyl-5-O-Methylvisamminol Attenuates Pro-Inflammatory Responses and Protects against Oxidative Damages
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Yoo, Ok-Kyung | - |
| dc.contributor.author | Keum, Young-Sam | - |
| dc.date.accessioned | 2023-04-28T03:40:49Z | - |
| dc.date.available | 2023-04-28T03:40:49Z | - |
| dc.date.issued | 2019-07 | - |
| dc.identifier.issn | 1976-9148 | - |
| dc.identifier.issn | 2005-4483 | - |
| dc.identifier.uri | https://scholarworks.dongguk.edu/handle/sw.dongguk/7920 | - |
| dc.description.abstract | We attempted to examine anti-inflammatory and anti-oxidant effects of 4'-O-beta-D-glucosy1-5-O-methylvisamminol (GOMV), the first epigenetic inhibitor of histone phosphorylation at Ser10. While GOMV did not affect the viability of murine macrophage RAW 264.7 cells, it significantly suppressed lipopolysaccharide (LPS)-induced generation of prostaglandin E-2 (PGE(2)) and nitric oxide (NO) through transcriptional inhibition of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS). GOMV also scavenged free radicals in vitro, increased NF-E2-related factor 2 (NRF2), and activated antioxidant response element (ARE), thereby resulting in the induction of phase II cytoprotective enzymes in human keratinocyte HaCaT cells. Finally, GOMV significantly protected HaCaT cells against 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced oxidative intracellular damages. Together, our results illustrate that GOMV possesses anti-inflammatory and anti-oxidant activity. | - |
| dc.format.extent | 5 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | KOREAN SOC APPLIED PHARMACOLOGY | - |
| dc.title | 4 '-O-beta-D-Glucosyl-5-O-Methylvisamminol Attenuates Pro-Inflammatory Responses and Protects against Oxidative Damages | - |
| dc.type | Article | - |
| dc.publisher.location | 대한민국 | - |
| dc.identifier.doi | 10.4062/biomolther.2018.232 | - |
| dc.identifier.scopusid | 2-s2.0-85070896247 | - |
| dc.identifier.wosid | 000473281700007 | - |
| dc.identifier.bibliographicCitation | BIOMOLECULES & THERAPEUTICS, v.27, no.4, pp 381 - 385 | - |
| dc.citation.title | BIOMOLECULES & THERAPEUTICS | - |
| dc.citation.volume | 27 | - |
| dc.citation.number | 4 | - |
| dc.citation.startPage | 381 | - |
| dc.citation.endPage | 385 | - |
| dc.type.docType | Article | - |
| dc.identifier.kciid | ART002480703 | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
| dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
| dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
| dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
| dc.subject.keywordPlus | HISTONE H3 PHOSPHORYLATION | - |
| dc.subject.keywordPlus | EPIGENETIC SUPPRESSOR | - |
| dc.subject.keywordPlus | ANTIOXIDANT CAPACITY | - |
| dc.subject.keywordPlus | SER10 | - |
| dc.subject.keywordPlus | NRF2 | - |
| dc.subject.keywordAuthor | 4 '-O-beta-D-glucosyl-5-O-methylvisamminol (GOMV) | - |
| dc.subject.keywordAuthor | Reactive oxygen species (ROS) | - |
| dc.subject.keywordAuthor | NF-E2-related factor 2 (NRF2) | - |
| dc.subject.keywordAuthor | Antioxidant response element (ARE) | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114
Copyright(c) 2023 DONGGUK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
